SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drugs informs about trading window closure

23 Jun 2026 Evaluate
Godavari Drugs has informed that the trading window for dealing in securities of the Company will remain closed for all Designated Persons and their immediate relatives from July 1, 2026 till 48 hours after declaration of the unaudited financial results of the Company for the quarter ending June 30, 2026 by the Company to the Stock Exchange. Accordingly all Connected/ Designated Persons and their relatives have been advised not to trade in the securities of the Company during the aforesaid period of closure of trading window.

The above information is a part of company’s filings submitted to BSE.

Godavari Drugs Share Price

120.50 -3.10 (-2.51%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: